Article Text
Abstract
This article considers the claim that gender diverse minors and their families should not be able to consent to hormonal treatment for gender dysphoria. The claim refers particularly to hormonal treatment with so-called ‘blockers’, analogues that suspend temporarily pubertal development. We discuss particularly four reasons why consent may be deemed invalid in these cases: (1) the decision is too complex; (2) the decision-makers are too emotionally involved; (3) the decision-makers are on a ‘conveyor belt’; (4) the possibility of detransitioning. We examine each of these reasons and we show that none of these stand up to scrutiny, and that some are based on a misunderstanding of the nature and purposes of this stage of treatment and of the circumstances in which it is usually prescribed. Moreover, accepting these claims at face value could have serious negative implications, not just for gender diverse youth, but for many other minors and families and in a much broader range of healthcare settings.
- legal aspects
- sexuality/gender
- clinical ethics
- informed consent
- minors/parental consent
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Two dilemmas for medical ethics in the treatment of gender dysphoria in youth
- What are the health outcomes of trans and gender diverse young people in Australia? Study protocol for the Trans20 longitudinal cohort study
- Assessment and support of children and adolescents with gender dysphoria
- Supporting autonomy in young people with gender dysphoria: psychotherapy is not conversion therapy
- High court should not restrict access to puberty blockers for minors
- Importance of being persistent. Should transgender children be allowed to transition socially?
- Defending two dilemmas
- Mature minors and gender dysphoria: a matter for clinicians not courts
- Gender dysphoria in young people is rising—and so is professional disagreement
- Longitudinal Outcomes of Gender Identity in Children (LOGIC): protocol for a prospective longitudinal cohort study of children referred to the UK gender identity development service